Day-by-Day Investigation Plan for Fever
For critically ill patients with new fever, perform a chest radiograph immediately and collect at least two sets of blood cultures (60 mL total) from different anatomical sites without delay, while reserving advanced imaging for cases where initial workup fails to identify an etiology. 1
Initial Assessment (Day 1)
Temperature Measurement
- Use oral or rectal temperatures as the standard method
- Central monitoring (pulmonary artery catheter thermistors, bladder catheters, esophageal thermistors) is preferred when these devices are already in place 1
- Avoid less reliable methods (axillary, tympanic, temporal artery, chemical dot thermometers)
Immediate Investigations - All Patients
Perform these without waiting:
- Chest radiograph - This is a best-practice statement for all ICU patients developing fever, as pneumonia is the most common infection causing fever in the ICU 1
- Blood cultures: Collect at least 2 sets (ideally 60 mL total) from different anatomical sites, drawn one after the other without time intervals 1
- Basic laboratory work: Complete blood count, basic metabolic panel, liver function tests
Device-Specific Sampling (Day 1)
- Central venous catheter present: Draw simultaneous central and peripheral blood cultures to calculate differential time to positivity; sample at least 2 lumens 1
- Urinary catheter with pyuria/suspected UTI: Replace the catheter and obtain cultures from the newly placed catheter 1
Respiratory Symptoms Present
- Viral testing: Use nucleic acid amplification test panels for viral pathogens if pneumonia or upper respiratory symptoms (cough) are present 1
- COVID-19 PCR: Test based on community transmission levels 1
Procalcitonin Consideration
- Measure procalcitonin if bacterial infection probability is low-to-intermediate with no clear focus, to supplement clinical evaluation 1
Days 1-2: Targeted Imaging Based on Clinical Context
Post-Surgical Patients
For recent thoracic, abdominal, or pelvic surgery: Perform CT imaging (in collaboration with surgical service) if initial workup doesn't identify an etiology 1
Abdominal Evaluation
- DO NOT perform routine abdominal ultrasound if patient has no abdominal signs/symptoms, normal liver function, and no recent abdominal surgery 1
- DO perform formal bedside diagnostic ultrasound if:
Chest Imaging Refinement
- If chest radiograph is abnormal: Consider thoracic bedside ultrasound (when expertise available) to better identify pleural effusions and parenchymal/interstitial pathology 1
Days 3-5: When Initial Workup is Unrevealing
Advanced Imaging
If other diagnostic tests have failed to establish etiology:
- Consider 18F-FDG PET/CT if transport risk is acceptable (sensitivity 85-100% for fever of unknown origin) 1
- WBC scans have insufficient evidence and are not routinely recommended 1
Management Considerations Throughout
Antipyretic Use
- Avoid routine antipyretics for the sole purpose of temperature reduction 1
- Use antipyretics (over nonpharmacologic methods) only when patient/family values comfort through temperature reduction 1
Rapid Molecular Testing
- If performed on blood, always use concomitantly with blood cultures, never as standalone tests 1
Critical Pitfalls to Avoid
Do not wait for "day 3" in critically ill patients - The evidence provided focuses on ICU patients where immediate investigation is warranted, unlike stable outpatients where observation may be appropriate 3
Do not perform CT scans as screening tools - Reserve for specific clinical indications to avoid unnecessary resource consumption and delays 2
Do not collect inadequate blood culture volumes - Insufficient sampling reduces diagnostic yield significantly
Do not skip lumbar puncture consideration in immunocompromised patients or those with neurological signs, though specific timing depends on clinical presentation
This algorithmic approach prioritizes early identification of life-threatening infections (pneumonia, bacteremia, surgical complications) while avoiding unnecessary testing in patients without specific clinical indicators. The strategy is based on 2023 Society of Critical Care Medicine and Infectious Diseases Society of America guidelines, representing the most current evidence-based approach to fever investigation 1.